A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
Clinical trial NCT06953986 · RECRUITING
Trial details
- NCT number
- NCT06953986
- Sponsor
- Asian Institute of Gastroenterology, India
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-20
- Primary completion
- 2026-11-20
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.